Patents by Inventor Robyn A. LINDLEY

Robyn A. LINDLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR PREDICTING THE EFFICACY OF CANCER THERAPY
    Publication number: 20240368705
    Abstract: This Invention relates generally to systems and methods for predicting the efficacy of a cancer therapy in a subject. The systems and methods of the disclosure can be used, for example, to determine a therapy indicator for use in assessing responsiveness to cancer therapy, to determine whether a subject is likely to respond to a new cancer therapy, and/or to determine whether a subject is likely to continue to respond to current cancer therapy.
    Type: Application
    Filed: July 10, 2024
    Publication date: November 7, 2024
    Applicant: GMDx Co Pty Ltd.
    Inventors: Nathan E. HALL, Jared MAMROT, Robyn A. LINDLEY
  • METHODS OF PREDICTING CANCER PROGRESSION
    Publication number: 20230242992
    Abstract: This invention relates generally to systems and methods of predicting the likelihood of cancer progression or recurrence. More particularly, the present invention relates to systems and methods of identifying nucleic acid mutation signatures that correlate with the likelihood of cancer recurrence or progression, and methods of using such signatures.
    Type: Application
    Filed: June 1, 2021
    Publication date: August 3, 2023
    Inventors: Robyn A. LINDLEY, Nathan E. HALL, Jared MAMROT
  • METHODS FOR DIAGNOSIS AND TREATMENT
    Publication number: 20220378913
    Abstract: Systems and methods for diagnosing and treating a neurodegenerative disorder in a subject can be used for the diagnosis of Mild Cognitive Impairment, Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, Parkinson's Disease, Dementia or Alzheimer's Disease in a subject, and for the treatment of a subject diagnosed with such neurodegenerative diseases.
    Type: Application
    Filed: October 26, 2020
    Publication date: December 1, 2022
    Inventors: Robyn LINDLEY, Nathan HALL, Jared MAMROT
  • Methods of detecting cancer recurrence
    Patent number: 11225690
    Abstract: Disclosed are methods of detecting the likelihood of cancer recurrence. More particularly, the present invention discloses methods of identifying nucleic acid signatures that correlate with the likelihood of cancer recurrence, and methods of using such signatures.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: January 18, 2022
    Assignee: GMDx Co Pty Ltd
    Inventor: Robyn Lindley
  • SYSTEMS AND METHODS FOR PREDICTING THE EFFICACY OF CANCER THERAPY
    Publication number: 20200370124
    Abstract: This invention relates generally to systems and methods for predicting the efficacy of a cancer therapy in a subject. The systems and methods of the disclosure can be used, for example, to determine a therapy indicator for use in assessing responsiveness to cancer therapy, to determine whether a subject is likely to respond to a new cancer therapy, and/or to determine whether a subject is likely to continue to respond to current cancer therapy.
    Type: Application
    Filed: November 16, 2018
    Publication date: November 26, 2020
    Applicant: GMDx Co Pty Ltd.
    Inventors: Nathan E. HALL, Jared MAMROT, Robyn A. LINDLEY
  • METHODS OF DETECTING CANCER RECURRENCE
    Publication number: 20200232038
    Abstract: Disclosed are methods of detecting the likelihood of cancer recurrence. More particularly, the present invention discloses methods of identifying nucleic acid signatures that correlate with the likelihood of cancer recurrence, and methods of using such signatures.
    Type: Application
    Filed: August 26, 2016
    Publication date: July 23, 2020
    Inventor: Robyn Lindley